MCDA EVIDEM REFERENCE VALUE FRAMEWORK FOR DRUG EVALUATION AND DECISION MAKING IN SPAIN

被引：7
|
作者：
Badia, X. [1 ]
Gil, A. [1 ]
Shepherd, J. [1 ]
机构：
[1] Omakase Consulting, Barcelona, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1063
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP169
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [21] Organizational Value Framework for Asset Management Decision-Making
    Barbieri, Giacomo
    Maria Benavides, Ana
    Alfredo Esteves, Luis
    Olaya, Camilo
    Zapata, Freddy
    IFAC PAPERSONLINE, 2024, 58 (08): : 395 - 400
  • [22] EVALUATION FOR DECISION-MAKING, CHOICE AND VALUE - PREFACE
    PROVUS, M
    JOURNAL OF RESEARCH AND DEVELOPMENT IN EDUCATION, 1970, 3 (04): : 1 - 12
  • [23] APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS (MCDA) TO DETERMINE THE VALUE OF TREATMENTS FOR THE MODERATE TO SEVERE PLAQUE PSORIASIS IN SPAIN
    Badia, X.
    de la Cueva, P.
    Rodriguez Moreda, F.
    Trillo, J. L.
    Guarga, L.
    VALUE IN HEALTH, 2017, 20 (09) : A564 - A564
  • [24] DETERMINING THE VALUE OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
    Jimenez, A.
    Ais, A.
    Acuna, L.
    Gonzalez, M. E.
    Paco, N.
    Gil, A.
    VALUE IN HEALTH, 2017, 20 (09) : A570 - A570
  • [25] TOWARDS JOINT DECISION MAKING: THE NEED FOR A FRAMEWORK TO ADDRESS ASYMMETRICAL VALUE
    Parkinson, M.
    Gonzalez, Olid A.
    VALUE IN HEALTH, 2020, 23 : S609 - S609
  • [26] A value based strategic knowledge framework to enable effective decision making
    Kumar, K. Sunil
    Muthuvelayutham, C.
    HUMAN SYSTEMS MANAGEMENT, 2014, 33 (03) : 71 - 77
  • [27] FRAMEWORK FOR DETERMINING VALUE OF DIAGNOSTIC INFORMATION FOR INSTRUCTIONAL DECISION-MAKING
    ARMSTRONG, DG
    EDUCATIONAL TECHNOLOGY, 1976, 16 (11) : 30 - 34
  • [28] Towards value-based pricing - An integrative framework for decision making
    Hinterhuber, A
    INDUSTRIAL MARKETING MANAGEMENT, 2004, 33 (08) : 765 - 778
  • [29] Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia
    Inotai, Andras
    Brixner, Diana
    Maniadakis, Nikos
    Dwiprahasto, Iwan
    Kristin, Erna
    Prabowo, Agus
    Yasmina, Alfi
    Priohutomo, Sigit
    Nemeth, Bertalan
    Wijaya, Kalman
    Kalo, Zoltan
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [30] Value contribution of Etranacogene dezaparvovec for the treatment of severe and moderately severe haemophilia B in Spain through multicriteria decision analysis (MCDA)
    Garcia Diego, Daniel-Anibal
    Jimenez-Yuste, Victor
    Nunez Vazquez, Ramiro
    Benitez Hidalgo, Olga
    Luis Poveda, Jose
    Juarez Gimenez, Juan Carlos
    Luis Trillo, Jose
    Valles, Joan-Antoni
    Perez-Santamarina, Rafael
    Badia, Xavier
    HAEMOPHILIA, 2024, 30 : 62 - 62
12345